325 related articles for article (PubMed ID: 35798798)
41. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
[TBL] [Abstract][Full Text] [Related]
42. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
43. Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma.
Liu M; Zhang Z; Zhang W; Liu SM
WIREs Mech Dis; 2023; 15(3):e1598. PubMed ID: 36697374
[TBL] [Abstract][Full Text] [Related]
44. Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma.
Lyu X; Tsui YM; Ho DW; Ng IO
Cell Mol Gastroenterol Hepatol; 2022; 13(6):1611-1624. PubMed ID: 35183803
[TBL] [Abstract][Full Text] [Related]
45. Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
Barault L; Amatu A; Siravegna G; Ponzetti A; Moran S; Cassingena A; Mussolin B; Falcomatà C; Binder AM; Cristiano C; Oddo D; Guarrera S; Cancelliere C; Bustreo S; Bencardino K; Maden S; Vanzati A; Zavattari P; Matullo G; Truini M; Grady WM; Racca P; Michels KB; Siena S; Esteller M; Bardelli A; Sartore-Bianchi A; Di Nicolantonio F
Gut; 2018 Nov; 67(11):1995-2005. PubMed ID: 28982739
[TBL] [Abstract][Full Text] [Related]
46. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.
Shitani M; Sasaki S; Akutsu N; Takagi H; Suzuki H; Nojima M; Yamamoto H; Tokino T; Hirata K; Imai K; Toyota M; Shinomura Y
Tumour Biol; 2012 Oct; 33(5):1307-17. PubMed ID: 22457049
[TBL] [Abstract][Full Text] [Related]
47. Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.
Holmila R; Sklias A; Muller DC; Degli Esposti D; Guilloreau P; Mckay J; Sangrajrang S; Srivatanakul P; Hainaut P; Merle P; Herceg Z; Nogueira da Costa A
PLoS One; 2017; 12(3):e0174265. PubMed ID: 28333958
[TBL] [Abstract][Full Text] [Related]
48. Methylation-sensitive high-resolution melting analysis of the USP44 promoter can detect early-stage hepatocellular carcinoma in blood samples.
Kim SC; Kim J; Kim DW; Choi Y; Park K; Cho EJ; Yu SJ; Kim-Ha J; Kim YJ
BMB Rep; 2022 Nov; 55(11):553-558. PubMed ID: 36016503
[TBL] [Abstract][Full Text] [Related]
49. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
50. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
51. Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma.
Oversoe SK; Clement MS; Weber B; Grønbæk H; Hamilton-Dutoit SJ; Sorensen BS; Kelsen J
BMC Cancer; 2021 Apr; 21(1):376. PubMed ID: 33827453
[TBL] [Abstract][Full Text] [Related]
52. Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma.
Jain S; Chen S; Chang KC; Lin YJ; Hu CT; Boldbaatar B; Hamilton JP; Lin SY; Chang TT; Chen SH; Song W; Meltzer SJ; Block TM; Su YH
PLoS One; 2012; 7(4):e35789. PubMed ID: 22536438
[TBL] [Abstract][Full Text] [Related]
53. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
He D; Liao S; Cai L; Huang W; Xie X; You M
BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705
[TBL] [Abstract][Full Text] [Related]
54. DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma.
Long J; Chen P; Lin J; Bai Y; Yang X; Bian J; Lin Y; Wang D; Yang X; Zheng Y; Sang X; Zhao H
Theranostics; 2019; 9(24):7251-7267. PubMed ID: 31695766
[TBL] [Abstract][Full Text] [Related]
55. Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes.
Stefanska B; Bouzelmat A; Huang J; Suderman M; Hallett M; Han ZG; Al-Mahtab M; Akbar SM; Khan WA; Raqib R; Szyf M
PLoS One; 2013; 8(8):e68439. PubMed ID: 23950870
[TBL] [Abstract][Full Text] [Related]
56. CpG-Islands as Markers for Liquid Biopsies of Cancer Patients.
Sprang M; Paret C; Faber J
Cells; 2020 Aug; 9(8):. PubMed ID: 32752173
[TBL] [Abstract][Full Text] [Related]
57. A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma.
Hao XY; Li AQ; Shi H; Guo TK; Shen YF; Deng Y; Wang LT; Wang T; Cai H
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33634306
[TBL] [Abstract][Full Text] [Related]
58. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial.
Alunni-Fabbroni M; Rönsch K; Huber T; Cyran CC; Seidensticker M; Mayerle J; Pech M; Basu B; Verslype C; Benckert J; Malfertheiner P; Ricke J
J Transl Med; 2019 Oct; 17(1):328. PubMed ID: 31570105
[TBL] [Abstract][Full Text] [Related]
59. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma.
Elzehery R; Effat N; El Farahaty R; Elsayed Farag R; Abo-Hashem EM; Elhelaly R
Am J Clin Pathol; 2022 Aug; 158(2):254-262. PubMed ID: 35403666
[TBL] [Abstract][Full Text] [Related]
60. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma.
Pezzuto F; Buonaguro L; Buonaguro FM; Tornesello ML
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29597259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
